DUORHIN RUPATADINE/MONTELUKAST
Live / Registered — Registered (as of 18 Mar 2025)
What this means for you
Registered since 18 Mar 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79393721
- Registration number
- 7726350
- Mark type
- Design + words
- Filed
- 17 Jan 2024
- Published for opposition
- 28 Jan 2025
- Registered
- 18 Mar 2025
- Attorney of record
- Angel Miguel Munoz, Esq.
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products based on rupatadine and montelukast being pharmaceutical preparations for use as antihistamines
Owner
Prosecution history
- 15 Nov 2025 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 03 Oct 2025 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
- 29 Sept 2025 — GENERIC MADRID TRANSACTION SENT TO IB
- 29 Sept 2025 — GENERIC MADRID TRANSACTION CREATED
- 17 Sept 2025 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 17 Sept 2025 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
- 19 Jun 2025 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 18 Mar 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 18 Mar 2025 — REGISTERED-PRINCIPAL REGISTER
- 28 Jan 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 28 Jan 2025 — PUBLISHED FOR OPPOSITION
- 22 Jan 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 26 Oct 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 25 Oct 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 25 Oct 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE